Trials / Suspended
SuspendedNCT00747669
Pharmacokinetic Study of Synera™ in Neonates and Infants
A Pharmacokinetic Study of Synera™ (Lidocaine 70 mg and Tetracaine 70 mg Topical Patch) to Evaluate the Systemic Exposure to Lidocaine and Tetracaine in Neonates and Infants
- Status
- Suspended
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 11 (estimated)
- Sponsor
- ZARS Pharma Inc. · Industry
- Sex
- All
- Age
- 4 Months
- Healthy volunteers
- Not accepted
Summary
This study will measure the amount of lidocaine and tetracaine in the blood after a 30 minute application of Synera.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lidocaine 70mg and tetracaine 70mg topical patch | One Synera Patch applied for 30 minutes. |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2008-09-05
- Last updated
- 2012-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00747669. Inclusion in this directory is not an endorsement.